Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor in the Treatment of Cognitive Impairment Associated with Huntingtons Disease
| SEVAX Fund | USD 43.69 0.01 0.02% |
Slightly above 55% of Guggenheim Mid's investor base is interested to short. The analysis of overall sentiment of trading Guggenheim Mid Cap mutual fund suggests that many investors are impartial at this time. Guggenheim Mid's investing sentiment can be driven by a variety of factors including economic data, Guggenheim Mid's earnings reports, geopolitical events, and overall market trends.
Guggenheim |
CAMBRIDGE, Mass., November 20, 2024--Sage Therapeutics, Inc. today announced topline results from the Phase 2 DIMENSION Study of dalzanemdor in participants with cognitive impairment associated with Huntingtons Disease . In the study, dalzanemdor did not demonstrate a statistically significant difference versus placebo on the primary endpoint, the change from baseline on the Symbol Digit Modalities Test at Day 84. Analyses of secondary endpoints did not
Read at finance.yahoo.com
 |
Guggenheim Mid Fundamental Analysis
We analyze Guggenheim Mid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guggenheim Mid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guggenheim Mid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Last Dividend Paid
Last Dividend Paid Comparative Analysis
Guggenheim Mid is currently under evaluation in last dividend paid among similar funds. Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
Guggenheim Mid Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guggenheim Mid mutual fund to make a market-neutral strategy. Peer analysis of Guggenheim Mid could also be used in its relative valuation, which is a method of valuing Guggenheim Mid by comparing valuation metrics with similar companies.
Peers
Guggenheim Mid Related Equities
| QUAKX | Ab Small | 0.55 | ||||
| HSCYX | The Hartford | 0.45 | ||||
| VISGX | Vanguard Small-cap | 0.42 | ||||
| JISGX | Jpmorgan Small | 0.42 | ||||
| LMBMX | Qs Us | 0.20 | ||||
| CWSIX | Chartwell Small | 0.17 | ||||
| BSGSX | Baird Small/mid | 0.50 |
Other Information on Investing in Guggenheim Mutual Fund
Guggenheim Mid financial ratios help investors to determine whether Guggenheim Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guggenheim with respect to the benefits of owning Guggenheim Mid security.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |